Provided by Tiger Trade Technology Pte. Ltd.

Progress

39.92
-0.6900-1.70%
Post-market: 39.920.00000.00%19:30 EDT
Volume:282.42K
Turnover:11.33M
Market Cap:1.64B
PE:19.28
High:41.21
Open:40.63
Low:39.82
Close:40.61
52wk High:47.37
52wk Low:23.82
Shares:41.01M
Float Shares:40.11M
Volume Ratio:0.69
T/O Rate:0.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.07
EPS(LYR):1.66
ROE:18.57%
ROA:4.89%
PB:3.24
PE(LYR):24.05

Loading ...

Profusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics Company

GlobeNewswire
·
Aug 20

Cerenome Highlights Presentations at the 2026 SNO/ASCO CNS Metastases Conference Demonstrating Progress in Both Therapeutics and Diagnostics Business Lines

GlobeNewswire
·
Aug 20

Kyle Peterson Reaffirms Hold on Alight, Citing Long Sales Cycles and Gradual Financial Impact Despite Strategic Progress

TIPRANKS
·
Aug 20

YSB Inc. Reports Integration Progress and Management Commitment on Key Acquisition

TIPRANKS
·
Aug 20

JINUSHI Publishes Q2 FY2026 Briefing, Confirms Strong Progress Toward Profit Targets

TIPRANKS
·
Aug 20

The Calmer Co. to Brief Investors on FY26 Progress and Strategic Priorities

TIPRANKS
·
Aug 20

Neuronetics Earnings Call: Progress Amid Transition Risks

TIPRANKS
·
Aug 20

Eureka Details Governance Compliance and Diversity Progress for FY26

TIPRANKS
·
Aug 20

Mirrabooka Updates Market on Progress of On-Market Share Buy-Back

TIPRANKS
·
Aug 20

Arcturus Therapeutics Earnings Call Balances Progress, Pressure

TIPRANKS
·
Aug 20

Dexus Industria REIT Updates ASX on Progress of On-Market Security Buy-Back

TIPRANKS
·
Aug 20

News Corp Details Progress on US$1bn Share Repurchase Program

TIPRANKS
·
Aug 20

Challenger Updates Investors on Progress of On-Market Share Buy-Back

TIPRANKS
·
Aug 20

Abaxx Maintained at Buy as Monetization Progress and Trading Growth Offset Longer Ramp-Up, Price Target Trimmed to $60

TIPRANKS
·
Aug 20

Rockwell Medical Maintained at Buy as Operational Progress and Discounted Valuation Support Upside Despite Cut to $20 Price Target

TIPRANKS
·
Aug 20

The Bull Case For PTC Therapeutics (PTCT) Could Change Following Renal Data Progress For ST-920

Simply Wall St.
·
Aug 20

Mirvac (ASX:MGR) Shares Reflect Repair Progress But Demand Doubts Linger

Simply Wall St.
·
Aug 20

Is Santos (ASX:STO) Fully Valued Following Softer Half Year Earnings And Project Progress?

Simply Wall St.
·
Aug 19

Target Investors See Tangible Progress in Turnaround

Dow Jones
·
Aug 19

Hillman Publishes 2025 Responsibility Report & Fact Sheet Highlighting Progress and Future Priorities

GlobeNewswire
·
Aug 19